Company Overview of Biopolymer Innovations, LLC
Biopolymer Innovations, LLC engages in the development of biodegradable, polysaccharide-based drug delivery systems. The company offers OcularGel, a drug delivery system for topical ocular drugs such as glaucoma, antibacterial, and anti-inflammation treatments. The company was founded in 2003 and is based in East Lansing, Michigan.
16647 Chandler Road
East Lansing, MI 48823
Founded in 2003
Key Executives for Biopolymer Innovations, LLC
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Biopolymer Innovations, LLC, please visit www.biopolymerinnovations.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.